S100A9 and cancer: As shown in Figure 2A, gradual decrease of S100A9-positive inflammatory cell count in cancer tissues was associated with the increase of tumor pathological stage from I to IV (Wilcoxon rank sum test for 4 stages, P = 0.0265).